INDEPENDENT ASSOCIATIONS BETWEEN PLASMA-LIPOPROTEIN SUBFRACTION LEVELS AND THE COURSE OF CORONARY-ARTERY DISEASE IN THE ST-THOMAS ATHEROSCLEROSIS-REGRESSION-STUDY (STARS)

被引:130
作者
WATTS, GF
MANDALIA, S
BRUNT, JNH
SLAVIN, BM
COLTART, DJ
LEWIS, B
机构
[1] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,DEPT CARDIOL,LONDON,ENGLAND
[2] UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,DEPT PUBL HLTH MED,LONDON,ENGLAND
[3] UNIV MANCHESTER,DEPT MED BIOPHYS,MANCHESTER M13 9PL,LANCS,ENGLAND
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 1993年 / 42卷 / 11期
关键词
D O I
10.1016/0026-0495(93)90199-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Associations between plasma lipoprotein subfractions and changes in coronary artery disease (CAD) were examined in 74 men who completed the St. Thomas' Atherosclerosis Regression Study (STARS). Plasma lipoproteins were isolated by stepwise, preparative ultracentrifugation at repeated intervals during the 38-month trial. Paired coronary angiograms were quantitatively analyzed by a computerized method. In univariate linear regression analysis, changes in mean absolute width (ΔMAWS) and minimum absolute width (ΔMinAWS) of coronary segments were significantly correlated with in-trial concentrations of cholesterol in intermediate-density lipoprotein ([IDL] d = 1.006 to 1.019 kg/L), low-density lipoprotein ([LDL2] d = 1.019 to 1.040 kg/L; LDL3, d = 1.040 to 1.063 kg/L), and high-density lipoprotein ([HDL3] d = 1.125 to 1.210 kg/L) subfractions; no significant associations were found with other lipoproteins. IDL, LDL3, and HDL3 cholesterol were then selected for multiple linear regression analysis because these variables were not co-correlated and because they attained a significance of P less than or equal to .1 in univariate regression. In this analysis, only LDL3 cholesterol level was a significant negative predictor (P < .05) of both ΔMAWS and ΔMinAWS; a positive association between ΔMinAWS and HDL3 cholesterol level just failed to reach conventional statistical significance (P = .066). Correlations between changes in coronary luminal dimensions and LDL3 cholesterol level were independent of age, smoking, weight, and blood pressure. Most patients showing regression of coronary atherosclerosis had an LDL3 cholesterol level of less than 1.8 mmol/L. The findings suggest that LDL3 is the plasma lipoprotein subfraction that exerts the single most powerful effect on the course of CAD in middle-aged men with hypercholesterolemia. © 1993.
引用
收藏
页码:1461 / 1467
页数:7
相关论文
共 42 条
[1]   DIET, LIPOPROTEINS, AND THE PROGRESSION OF CORONARY ATHEROSCLEROSIS - THE LEIDEN INTERVENTION TRIAL [J].
ARNTZENIUS, AC ;
KROMHOUT, D ;
BARTH, JD ;
REIBER, JHC ;
BRUSCHKE, AVG ;
BUIS, B ;
VANGENT, CM ;
KEMPENVOOGD, N ;
STRIKWERDA, S ;
VANDERVELDE, EA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (13) :805-811
[2]  
AUSTIN MA, 1988, JAMA-J AM MED ASSOC, V260, P1917
[3]   ATHEROGENIC LIPOPROTEIN PHENOTYPE - A PROPOSED GENETIC-MARKER FOR CORONARY HEART-DISEASE RISK [J].
AUSTIN, MA ;
KING, MC ;
VRANIZAN, KM ;
KRAUSS, RM .
CIRCULATION, 1990, 82 (02) :495-506
[4]   RELATIONSHIP BETWEEN APOLIPOPROTEINS AND CHEMICAL-COMPONENTS OF LIPOPROTEINS IN SURVIVORS OF MYOCARDIAL-INFARCTION [J].
AVOGARO, P ;
BITTOLOBON, G ;
CAZZOLATO, G ;
RORAI, E .
ATHEROSCLEROSIS, 1980, 37 (01) :69-76
[5]  
BARTH JD, 1987, J CARDIOVASC PHAR S9, V10, P542
[6]   PREDICTION OF ANGIOGRAPHIC CHANGE IN NATIVE HUMAN CORONARY-ARTERIES AND AORTOCORONARY BYPASS GRAFTS - LIPID AND NONLIPID FACTORS [J].
BLANKENHORN, DH ;
ALAUPOVIC, P ;
WICKHAM, E ;
CHIN, HP ;
AZEN, SP .
CIRCULATION, 1990, 81 (02) :470-476
[7]   HIGH-DENSITY LIPOPROTEIN SUBFRACTIONS IN NORMOLIPIDEMIC PATIENTS WITH CORONARY ATHEROSCLEROSIS [J].
BROOK, JG ;
AVIRAM, M ;
VIENER, A ;
SHILANSKY, E ;
MARKIEWICZ, W .
CIRCULATION, 1982, 66 (05) :923-926
[8]   ARTERIOGRAPHIC ASSESSMENT OF CORONARY ATHEROSCLEROSIS - REVIEW OF CURRENT METHODS, THEIR LIMITATIONS, AND CLINICAL-APPLICATIONS [J].
BROWN, BG ;
BOLSON, EL ;
DODGE, HT .
ARTERIOSCLEROSIS, 1982, 2 (01) :2-15
[9]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298
[10]  
BRUNT JNH, 1992, CLIN SCI, V83, pP6